Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Mabs|August 10, 2019
Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasisRyo Hatano, Takumi Itoh, Haruna Otsuka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumorsTeruo Inamoto, Taketo Yamada, Kei Ohnuma, et al.
Oncogene|December 14, 2004
HTLV-I Tax induces and associates with Crk-associated substrate lymphocyte type (Cas-L)Satoshi Iwata, Akiko Souta-Kuribara, Akio Yamakawa, et al.
Case Reports in Oncological Medicine|March 20, 2015
New primary malignancy masquerading as metastatic prostate adenocarcinomaEllen A Szwed, Sarunas Sliesoraitis, Thu-Cuc Nguyen, et al.
ACS Chemical Biology|March 4, 2016
Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal CancerMichelle S Bousquet, Jia Jia Ma, Ranjala Ratnayake, et al.
Journal of Dermatological Science|April 3, 2017
A possible role for CD26/DPPIV enzyme activity in the regulation of psoriatic pruritusEriko Komiya, Ryo Hatano, Haruna Otsuka, et al.
Plos One|January 30, 2026
Antiapoptotic BCL2 family proteins BCL-XL and MCL1 as factors predicting resistance against venetoclax plus azacitidine for patients with newly diagnosed acute myelogenous leukemiaYusuke Kamihara, Shohei Kikuchi, Nanako Ishikawa, et al.
Plos One|June 14, 2019
Development of novel monoclonal antibodies with specific binding affinity for denatured human CD26 in formalin-fixed paraffin-embedded and decalcified specimensRyo Hatano, Taketo Yamada, Hiroko Madokoro, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2014
Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 studyBradford S Hoppe, Stella Flampouri, Robert Zaiden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2012
CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesotheliomaKeisuke Aoe, Vishwa Jeet Amatya, Nobukazu Fujimoto, et al.
Pageof 13